Navigation Links
Clinical Trial Results, Litigation Outcomes and Marketing Authorizations - Research Report on Pfizer, GlaxoSmithKline, Sanofi, AstraZeneca, and Neurocrine
Date:9/19/2013

0 mg dose in Phase IIb Kinect study did not meet the primary endpoint, while the 100mg dose showed a statistical and clinically significant improvement. "Although this was not the result we anticipated in the 50mg dose based on the data set from the earlier clinical studies, we were pleased to see a clear dose related response at the end of Week 2, with the 100mg dose," said Kevin C. Gorman, President and CEO of Neurocrine. "The 100mg dose was statistically superior to placebo as well as providing a clinically significant improvement in tardive dyskinesia symptoms and importantly a very good safety profile. We will now perform an additional Phase II study utilizing 100mg and higher doses." The Full Research Report on Neurocrine Biosciences, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-09-17/NBIX]

----

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  5. For any urgent concerns or inquiries, please contact us at

SOURCE Investors' Reports
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
2. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
3. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
4. AtheroNova Signs Agreement for Development of Clinical Trial Supplies
5. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
6. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
7. New Clinical Endocrinology Guidelines Support Lp-PLA2 Measurement For Risk Assessment of Coronary Artery Disease
8. First Patient Treated in U.S. Clinical Study of Cohera Medicals TissuGlu® Surgical Adhesive
9. Michael J. Fox Foundation-Funded Study Identifies Best Dyskinesia Clinical Rating Scale
10. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
11. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... - The issue: In consultation ... lot (lot 710535) of Clavulin-400 (70mL) after receiving a complaint ... in one bottle of the  product. No other lots of ... Clavulin-400 is an oral antibiotic used in adults and children ... Clavulin-400 comes as a powder in bottles and is mixed ...
(Date:4/17/2015)... N.C. , April 17, 2015 ... the Integrated Embolic Protection™ filter platform for angioplasty ... of a $5.6 million Series B financing round ... venture firm with a focus on medical devices, ... The round also included Mountain Group Partners, Lookout ...
(Date:4/17/2015)... , April 17, 2015  Regulatory leaders in the ... bipartisan discussion draft called "21 st Century Cures." ... to be taken up by Congress soon and if ... medical device products are developed and marketed in ... many companies have begun to consider how the proposed ...
Breaking Medicine Technology:Advisory - Clavulin-400 liquid oral antibiotic: One lot recalled after glass pieces found in one bottle 2Contego Medical Closes $5.6 Million in Series B Funding 2Contego Medical Closes $5.6 Million in Series B Funding 321st Century Cures: A Regulatory Game-Changer for the Pharmaceutical Industry 2
... able to save part of each kidney in ... tumors appear on preoperative,scans, MEMPHIS, Tenn., March ... demonstrated that children with bilateral,Wilms tumor, a cancer ... both,kidneys by undergoing a procedure called bilateral nephron-sparing ...
... Pre-existing Lamivudine Resistance Predisposes Patients to ... Higher Rates of BARACLUDE Resistance ... data presented today demonstrated a continued low incidence of,resistance ... nucleoside-naive chronic hepatitis B patients analyzed, no additional,patient developed ...
Cached Medicine Technology:St. Jude Study Offers New Hope for Children With Kidney Tumors Deemed Inoperable 2BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 2BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 3BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 4BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 5BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 6
(Date:4/19/2015)... Houston, Texas (PRWEB) April 19, 2015 ... is pleased to announce the publication of white paper ... Online Affair . As online media provides a ... whole new niche market specifically targeting adulterous spouses ... which an affair becomes as easy as shopping online. ...
(Date:4/18/2015)... April 19, 2015 The Residential ... during the past five years. The industry, which provides ... unable to fully care for themselves, has boomed on ... for dementia care for seniors with memory impairment. As ... an annualized rate of 4.1% to $1.9 billion over ...
(Date:4/18/2015)... PA (PRWEB) April 18, 2015 "I ... evacuation stretchers in healthcare facilities," said an inventor from ... alternative storage system." , He developed the Slyde Door ... doors used in healthcare facilities. It provides convenient storage ... there are more stretchers available for patients. , ...
(Date:4/18/2015)... 2015 Lower-auto-insurance.com has released a new ... auto insurance quotes . , Drivers can find ... quotes. A professional insurance brokerage website can help drivers ... a simple, convenient way. The whole process is designed ... , Comparing online car insurance quotes is advantageous because ...
(Date:4/18/2015)... On April 14th, 2015, Symantec released ... they say, “exposes a tactical shift by cyberattackers.” With everything ... introduced in 2014 - almost a million a day - ... be identified and patched by prominent manufacturers – as long ... business in a digital world can be fraught with peril, ...
Breaking Medicine News(10 mins):Health News:McCann Investigations Publishes White Paper Married, but Dating: The Rise of the Married Online Affair 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Auto Insurance Quotes Can Provide Accurate Results! 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5
... prevention office of the Ministry of Health released a data ... which//, around 45,000 new cases of eyesight loss are reported ... reported 12 million people handicapped with eye problems, including about ... director with the blindness prevention office in East China's Shandong ...
... sickness or Human African trypanosomiasis is caused by the bite ... passes on the parasite called the trypanosome, to human beings ... disease over the past two decades in Sub-Saharan Africa. The ... of the number of people suffering this sickness, which is ...
... for protection of traditional medicines that they say is ... practitioners. ,Mei Zhinan, an expert in traditional ... said 80 percent of China's 55 minority groups, accounting ... billion population, had their own traditional medicines and secret ...
... accredited NewYork-Presbyterian Hospital as a Bariatric Surgery Center Network ... recognition of the Hospital's ability to offer patients the ... for New York state and one of only seven ... 20 years of age and older are obese -- ...
... by S. Kankova and colleagues from the Departments of ... Reproductive Medicine; and GynCentrum, in the Czech Republic, women ... than women who are Toxoplasma negative. // ... in human with a universal occurrence of 20-80%. This ...
... role in longevity, with longer-lived rodents showing significantly lower ... new study has found.// ,The study further strengthens ... shorter its life, and vice versa, said Mario Pinto, ... regulate metabolic rate. ,“Thyroid hormones are key ...
Cached Medicine News:Health News:Understanding Sleeping Sickness 2Health News:Understanding Sleeping Sickness 3Health News:Chinese Experts Call for Protection of Traditional Medicines 2Health News:NewYork-Presbyterian Receives Highest Accreditation for Bariatric Surgery 2Health News:Effect of parasitic infection on baby's sex 2Health News:Longer-Lived Rodents Have Lower Levels of Thyroid Hormone 2
... The VASER System represents a ... ultrasonic technology to cosmetic procedures. Combined ... selective tissue emulsification, a solid grooved ... the VASER System has been designed ...
... The next generation of the ... PSI-TEC III retains all the ... PSI-TEC a leading name for,aspiration ... flow,vacuum pumps for high powered ...
Richardson Retractor...
Our most popular saline breast implant style for over 20 years. A full, rounded look that adds greater dimension to the breast....
Medicine Products: